nodes	percent_of_prediction	percent_of_DWPC	metapath
Sucralfate—EGF—submandibular gland—head and neck cancer	0.126	0.379	CbGeAlD
Sucralfate—EGF—exocrine gland—head and neck cancer	0.023	0.0689	CbGeAlD
Sucralfate—EGF—mouth—head and neck cancer	0.0172	0.0515	CbGeAlD
Sucralfate—EGF—neck—head and neck cancer	0.0147	0.0441	CbGeAlD
Sucralfate—PGA5—head—head and neck cancer	0.0146	0.0438	CbGeAlD
Sucralfate—FGB—lymphoid tissue—head and neck cancer	0.0123	0.0369	CbGeAlD
Sucralfate—EGF—parotid gland—head and neck cancer	0.012	0.0359	CbGeAlD
Sucralfate—EGF—saliva-secreting gland—head and neck cancer	0.0115	0.0344	CbGeAlD
Sucralfate—FGA—lymphoid tissue—head and neck cancer	0.0105	0.0316	CbGeAlD
Sucralfate—EGF—connective tissue—head and neck cancer	0.0105	0.0316	CbGeAlD
Sucralfate—EGF—epithelium—head and neck cancer	0.01	0.03	CbGeAlD
Sucralfate—FGG—lymph node—head and neck cancer	0.00901	0.027	CbGeAlD
Sucralfate—EGF—trachea—head and neck cancer	0.00885	0.0265	CbGeAlD
Sucralfate—FGA—head—head and neck cancer	0.0085	0.0255	CbGeAlD
Sucralfate—FGF2—trachea—head and neck cancer	0.0078	0.0234	CbGeAlD
Sucralfate—EGF—lymphoid tissue—head and neck cancer	0.0077	0.0231	CbGeAlD
Sucralfate—EGF—thyroid gland—head and neck cancer	0.007	0.021	CbGeAlD
Sucralfate—EGF—head—head and neck cancer	0.00621	0.0186	CbGeAlD
Sucralfate—FGF2—thyroid gland—head and neck cancer	0.00617	0.0185	CbGeAlD
Sucralfate—EGF—lymph node—head and neck cancer	0.00435	0.013	CbGeAlD
Sucralfate—FGF2—lymph node—head and neck cancer	0.00384	0.0115	CbGeAlD
Sucralfate—ALB—lymph node—head and neck cancer	0.0015	0.0045	CbGeAlD
Sucralfate—FGF2—Signaling by FGFR—HRAS—head and neck cancer	0.000302	0.000453	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—PIK3CA—head and neck cancer	0.000301	0.000452	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—HRAS—head and neck cancer	0.0003	0.000451	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—HRAS—head and neck cancer	0.000299	0.000448	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—PIK3CA—head and neck cancer	0.000298	0.000448	CbGpPWpGaD
Sucralfate—FGF2—Signaling by SCF-KIT—AKT1—head and neck cancer	0.000298	0.000447	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—PIK3CA—head and neck cancer	0.000297	0.000446	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—HRAS—head and neck cancer	0.000295	0.000442	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—PTEN—head and neck cancer	0.000293	0.00044	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—NOTCH1—head and neck cancer	0.000293	0.000439	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—BCL2L1—head and neck cancer	0.000288	0.000432	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000286	0.000429	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling of activated FGFR—AKT1—head and neck cancer	0.000285	0.000428	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—PIK3CA—head and neck cancer	0.000281	0.000422	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—HRAS—head and neck cancer	0.000281	0.000422	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—HRAS—head and neck cancer	0.000281	0.000422	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—HRAS—head and neck cancer	0.000281	0.000422	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—AKT1—head and neck cancer	0.00028	0.000421	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—HRAS—head and neck cancer	0.000279	0.000418	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—AKT1—head and neck cancer	0.000277	0.000415	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000277	0.000415	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—HRAS—head and neck cancer	0.000276	0.000414	CbGpPWpGaD
Sucralfate—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	0.000276	0.000414	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—HRAS—head and neck cancer	0.000275	0.000413	CbGpPWpGaD
Sucralfate—ALB—Metabolism—UROD—head and neck cancer	0.000273	0.000409	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—AKT1—head and neck cancer	0.000271	0.000407	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—AKT1—head and neck cancer	0.000271	0.000407	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—PIK3CA—head and neck cancer	0.000269	0.000404	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—AKT1—head and neck cancer	0.000268	0.000402	CbGpPWpGaD
Sucralfate—ALB—Platelet degranulation—VEGFA—head and neck cancer	0.000268	0.000402	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—AKT1—head and neck cancer	0.000267	0.000401	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—AKT1—head and neck cancer	0.000266	0.0004	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—VEGFA—head and neck cancer	0.000265	0.000398	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—AKT1—head and neck cancer	0.000265	0.000398	CbGpPWpGaD
Sucralfate—EGF—Immune System—BCL2L1—head and neck cancer	0.000265	0.000398	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—PTEN—head and neck cancer	0.000264	0.000397	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—AKT1—head and neck cancer	0.000264	0.000396	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—STAT3—head and neck cancer	0.000262	0.000394	CbGpPWpGaD
Sucralfate—FGA—Disease—PTGS2—head and neck cancer	0.000261	0.000392	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—HRAS—head and neck cancer	0.00026	0.00039	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—AKT1—head and neck cancer	0.00026	0.00039	CbGpPWpGaD
Sucralfate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—head and neck cancer	0.000255	0.000383	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—PTEN—head and neck cancer	0.000254	0.000381	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—NOTCH1—head and neck cancer	0.000252	0.000377	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—GRP—head and neck cancer	0.000251	0.000377	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—MAPK3—head and neck cancer	0.000251	0.000377	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—MAPK3—head and neck cancer	0.000251	0.000376	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—HRAS—head and neck cancer	0.000249	0.000374	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—AKT1—head and neck cancer	0.000248	0.000372	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—AKT1—head and neck cancer	0.000248	0.000372	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—AKT1—head and neck cancer	0.000248	0.000372	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—NOTCH1—head and neck cancer	0.000246	0.00037	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—NOTCH1—head and neck cancer	0.000246	0.00037	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—AKT1—head and neck cancer	0.000246	0.000369	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—STAT6—head and neck cancer	0.000244	0.000366	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—AKT1—head and neck cancer	0.000244	0.000366	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—AKT1—head and neck cancer	0.000243	0.000364	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—MAPK1—head and neck cancer	0.000239	0.000358	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—MAPK1—head and neck cancer	0.000239	0.000358	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—EGFR—head and neck cancer	0.000238	0.000358	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—TP53—head and neck cancer	0.000236	0.000354	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—CASP8—head and neck cancer	0.000235	0.000353	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000234	0.00035	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—AKT1—head and neck cancer	0.00023	0.000345	CbGpPWpGaD
Sucralfate—FGA—Disease—PTEN—head and neck cancer	0.000228	0.000342	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—MAPK3—head and neck cancer	0.000226	0.000339	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—CDH1—head and neck cancer	0.000223	0.000335	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—AKT1—head and neck cancer	0.00022	0.00033	CbGpPWpGaD
Sucralfate—EGF—Disease—NOTCH1—head and neck cancer	0.00022	0.00033	CbGpPWpGaD
Sucralfate—EGF—Immune System—CASP8—head and neck cancer	0.000217	0.000325	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—YAP1—head and neck cancer	0.000216	0.000324	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—MAPK1—head and neck cancer	0.000215	0.000323	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—EGFR—head and neck cancer	0.000215	0.000323	CbGpPWpGaD
Sucralfate—EGF—Immune System—CDH1—head and neck cancer	0.000214	0.000321	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000211	0.000317	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—PIK3CA—head and neck cancer	0.000207	0.000311	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—PIK3CA—head and neck cancer	0.000207	0.000311	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—EGFR—head and neck cancer	0.000206	0.00031	CbGpPWpGaD
Sucralfate—FGA—Disease—STAT3—head and neck cancer	0.000204	0.000306	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—BCL2—head and neck cancer	0.000202	0.000303	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—TP53—head and neck cancer	0.0002	0.000301	CbGpPWpGaD
Sucralfate—FGA—Disease—MAPK3—head and neck cancer	0.000195	0.000292	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—HRAS—head and neck cancer	0.000192	0.000288	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—HRAS—head and neck cancer	0.000192	0.000287	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—PIK3CA—head and neck cancer	0.000187	0.00028	CbGpPWpGaD
Sucralfate—EGF—Immune System—BCL2—head and neck cancer	0.000186	0.000279	CbGpPWpGaD
Sucralfate—FGA—Disease—MAPK1—head and neck cancer	0.000185	0.000278	CbGpPWpGaD
Sucralfate—FGA—Disease—EGFR—head and neck cancer	0.000185	0.000278	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—PIK3CA—head and neck cancer	0.000179	0.000269	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—IL2—head and neck cancer	0.000173	0.00026	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—HRAS—head and neck cancer	0.000173	0.000259	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—VEGFA—head and neck cancer	0.000171	0.000257	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—IL2—head and neck cancer	0.00017	0.000254	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—IL2—head and neck cancer	0.00017	0.000254	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—STAT3—head and neck cancer	0.000169	0.000254	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—AKT1—head and neck cancer	0.000169	0.000254	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—AKT1—head and neck cancer	0.000169	0.000254	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CCND1—head and neck cancer	0.000169	0.000253	CbGpPWpGaD
Sucralfate—FGF2—Immune System—BCL2L1—head and neck cancer	0.000168	0.000252	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—PTEN—head and neck cancer	0.000167	0.000251	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—HRAS—head and neck cancer	0.000166	0.000249	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CCND1—head and neck cancer	0.000165	0.000248	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CCND1—head and neck cancer	0.000165	0.000248	CbGpPWpGaD
Sucralfate—EGF—Immune System—IL2—head and neck cancer	0.000164	0.000246	CbGpPWpGaD
Sucralfate—EGF—Disease—PTGS2—head and neck cancer	0.000163	0.000245	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—PTEN—head and neck cancer	0.000163	0.000244	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—MAPK3—head and neck cancer	0.000162	0.000243	CbGpPWpGaD
Sucralfate—FGA—Disease—PIK3CA—head and neck cancer	0.000161	0.000241	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—PTEN—head and neck cancer	0.000161	0.000241	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—PTEN—head and neck cancer	0.00016	0.000239	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—PTEN—head and neck cancer	0.00016	0.000239	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—MAPK1—head and neck cancer	0.000154	0.000231	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—EGFR—head and neck cancer	0.000154	0.000231	CbGpPWpGaD
Sucralfate—EGF—Immune System—PTEN—head and neck cancer	0.000154	0.000231	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—NOTCH1—head and neck cancer	0.000154	0.000231	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—AKT1—head and neck cancer	0.000152	0.000229	CbGpPWpGaD
Sucralfate—FGA—Disease—HRAS—head and neck cancer	0.000149	0.000223	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—VEGFA—head and neck cancer	0.000147	0.000221	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—AKT1—head and neck cancer	0.000146	0.00022	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—STAT3—head and neck cancer	0.000146	0.000219	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—VEGFA—head and neck cancer	0.000144	0.000216	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—VEGFA—head and neck cancer	0.000144	0.000216	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—MAPK3—head and neck cancer	0.000143	0.000215	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—STAT3—head and neck cancer	0.000143	0.000214	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—STAT3—head and neck cancer	0.000143	0.000214	CbGpPWpGaD
Sucralfate—EGF—Disease—PTEN—head and neck cancer	0.000142	0.000213	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—IL2—head and neck cancer	0.00014	0.00021	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—MAPK3—head and neck cancer	0.000139	0.000209	CbGpPWpGaD
Sucralfate—FGF2—Disease—NOTCH1—head and neck cancer	0.000139	0.000209	CbGpPWpGaD
Sucralfate—EGF—Immune System—STAT3—head and neck cancer	0.000138	0.000207	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CASP8—head and neck cancer	0.000137	0.000206	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—MAPK3—head and neck cancer	0.000136	0.000205	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—MAPK3—head and neck cancer	0.000136	0.000205	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—MAPK1—head and neck cancer	0.000136	0.000204	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—EGFR—head and neck cancer	0.000136	0.000204	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CDH1—head and neck cancer	0.000135	0.000203	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—MAPK1—head and neck cancer	0.000132	0.000199	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—EGFR—head and neck cancer	0.000132	0.000199	CbGpPWpGaD
Sucralfate—EGF—Immune System—MAPK3—head and neck cancer	0.000132	0.000197	CbGpPWpGaD
Sucralfate—FGA—Disease—AKT1—head and neck cancer	0.000131	0.000197	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—EGFR—head and neck cancer	0.000131	0.000196	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—MAPK1—head and neck cancer	0.00013	0.000195	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—MAPK1—head and neck cancer	0.00013	0.000195	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—EGFR—head and neck cancer	0.00013	0.000195	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—EGFR—head and neck cancer	0.00013	0.000195	CbGpPWpGaD
Sucralfate—EGF—Disease—STAT3—head and neck cancer	0.000127	0.000191	CbGpPWpGaD
Sucralfate—EGF—Immune System—MAPK1—head and neck cancer	0.000125	0.000188	CbGpPWpGaD
Sucralfate—EGF—Immune System—EGFR—head and neck cancer	0.000125	0.000188	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—HRAS—head and neck cancer	0.000124	0.000186	CbGpPWpGaD
Sucralfate—EGF—Disease—MAPK3—head and neck cancer	0.000121	0.000182	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.00012	0.00018	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000119	0.000179	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	0.000119	0.000178	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—PIK3CA—head and neck cancer	0.000118	0.000177	CbGpPWpGaD
Sucralfate—FGF2—Immune System—BCL2—head and neck cancer	0.000118	0.000177	CbGpPWpGaD
Sucralfate—EGF—Disease—MAPK1—head and neck cancer	0.000116	0.000173	CbGpPWpGaD
Sucralfate—EGF—Disease—EGFR—head and neck cancer	0.000116	0.000173	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—PIK3CA—head and neck cancer	0.000115	0.000172	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—PIK3CA—head and neck cancer	0.000113	0.00017	CbGpPWpGaD
Sucralfate—ALB—Metabolism—NAT2—head and neck cancer	0.000113	0.00017	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—PIK3CA—head and neck cancer	0.000113	0.000169	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—PIK3CA—head and neck cancer	0.000113	0.000169	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	0.000112	0.000169	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TP53—head and neck cancer	0.000111	0.000167	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—HRAS—head and neck cancer	0.000109	0.000164	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—AKT1—head and neck cancer	0.000109	0.000164	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TP53—head and neck cancer	0.000109	0.000163	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TP53—head and neck cancer	0.000109	0.000163	CbGpPWpGaD
Sucralfate—EGF—Immune System—PIK3CA—head and neck cancer	0.000109	0.000163	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	0.000107	0.00016	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—HRAS—head and neck cancer	0.000106	0.00016	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—IL2—head and neck cancer	0.000106	0.000159	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—HRAS—head and neck cancer	0.000105	0.000157	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—HRAS—head and neck cancer	0.000104	0.000156	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—HRAS—head and neck cancer	0.000104	0.000156	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IL2—head and neck cancer	0.000104	0.000155	CbGpPWpGaD
Sucralfate—FGF2—Disease—PTGS2—head and neck cancer	0.000103	0.000155	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CCND1—head and neck cancer	0.000103	0.000155	CbGpPWpGaD
Sucralfate—EGF—Immune System—HRAS—head and neck cancer	0.000101	0.000151	CbGpPWpGaD
Sucralfate—EGF—Disease—PIK3CA—head and neck cancer	0.0001	0.000151	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PTEN—head and neck cancer	9.96e-05	0.000149	CbGpPWpGaD
Sucralfate—ALB—Metabolism—DPYD—head and neck cancer	9.92e-05	0.000149	CbGpPWpGaD
Sucralfate—FGF2—Immune System—PTEN—head and neck cancer	9.75e-05	0.000146	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NOTCH1—head and neck cancer	9.73e-05	0.000146	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—AKT1—head and neck cancer	9.64e-05	0.000145	CbGpPWpGaD
Sucralfate—ALB—Metabolism—YAP1—head and neck cancer	9.42e-05	0.000141	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—AKT1—head and neck cancer	9.39e-05	0.000141	CbGpPWpGaD
Sucralfate—EGF—Disease—HRAS—head and neck cancer	9.28e-05	0.000139	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	9.28e-05	0.000139	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—AKT1—head and neck cancer	9.26e-05	0.000139	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—AKT1—head and neck cancer	9.2e-05	0.000138	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—AKT1—head and neck cancer	9.2e-05	0.000138	CbGpPWpGaD
Sucralfate—FGF2—Disease—PTEN—head and neck cancer	9e-05	0.000135	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—VEGFA—head and neck cancer	8.99e-05	0.000135	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—STAT3—head and neck cancer	8.91e-05	0.000134	CbGpPWpGaD
Sucralfate—EGF—Immune System—AKT1—head and neck cancer	8.88e-05	0.000133	CbGpPWpGaD
Sucralfate—FGF2—Immune System—STAT3—head and neck cancer	8.72e-05	0.000131	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—MAPK3—head and neck cancer	8.51e-05	0.000128	CbGpPWpGaD
Sucralfate—FGF2—Immune System—MAPK3—head and neck cancer	8.33e-05	0.000125	CbGpPWpGaD
Sucralfate—EGF—Disease—AKT1—head and neck cancer	8.19e-05	0.000123	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—MAPK1—head and neck cancer	8.1e-05	0.000121	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—EGFR—head and neck cancer	8.09e-05	0.000121	CbGpPWpGaD
Sucralfate—FGF2—Disease—STAT3—head and neck cancer	8.05e-05	0.000121	CbGpPWpGaD
Sucralfate—FGF2—Immune System—MAPK1—head and neck cancer	7.92e-05	0.000119	CbGpPWpGaD
Sucralfate—FGF2—Immune System—EGFR—head and neck cancer	7.92e-05	0.000119	CbGpPWpGaD
Sucralfate—FGF2—Disease—MAPK3—head and neck cancer	7.69e-05	0.000115	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	7.58e-05	0.000114	CbGpPWpGaD
Sucralfate—FGF2—Disease—MAPK1—head and neck cancer	7.32e-05	0.00011	CbGpPWpGaD
Sucralfate—FGF2—Disease—EGFR—head and neck cancer	7.31e-05	0.00011	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—IL2—head and neck cancer	7.2e-05	0.000108	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	7.08e-05	0.000106	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PIK3CA—head and neck cancer	7.02e-05	0.000105	CbGpPWpGaD
Sucralfate—FGF2—Immune System—PIK3CA—head and neck cancer	6.88e-05	0.000103	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TP53—head and neck cancer	6.8e-05	0.000102	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IL2—head and neck cancer	6.7e-05	0.000101	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CCND1—head and neck cancer	6.53e-05	9.8e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—HRAS—head and neck cancer	6.5e-05	9.75e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—HRAS—head and neck cancer	6.36e-05	9.55e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—PIK3CA—head and neck cancer	6.35e-05	9.53e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PTEN—head and neck cancer	6.3e-05	9.46e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.17e-05	9.26e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—VEGFA—head and neck cancer	6.12e-05	9.19e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—HRAS—head and neck cancer	5.87e-05	8.81e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—MAPK3—head and neck cancer	5.79e-05	8.69e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—AKT1—head and neck cancer	5.74e-05	8.61e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—VEGFA—head and neck cancer	5.69e-05	8.54e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—TYMS—head and neck cancer	5.65e-05	8.49e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—STAT3—head and neck cancer	5.64e-05	8.46e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—AKT1—head and neck cancer	5.62e-05	8.43e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GSTM1—head and neck cancer	5.59e-05	8.39e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—MAPK1—head and neck cancer	5.51e-05	8.27e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MAPK3—head and neck cancer	5.38e-05	8.08e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GPX1—head and neck cancer	5.35e-05	8.03e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CYP1A1—head and neck cancer	5.3e-05	7.95e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—AKT1—head and neck cancer	5.19e-05	7.78e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MAPK1—head and neck cancer	5.12e-05	7.69e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—EGFR—head and neck cancer	5.12e-05	7.69e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—PIK3CA—head and neck cancer	4.78e-05	7.18e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—TP53—head and neck cancer	4.63e-05	6.94e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PIK3CA—head and neck cancer	4.45e-05	6.67e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—HRAS—head and neck cancer	4.42e-05	6.64e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.35e-05	6.53e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TP53—head and neck cancer	4.3e-05	6.45e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—HRAS—head and neck cancer	4.11e-05	6.17e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—AKT1—head and neck cancer	3.91e-05	5.86e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—AKT1—head and neck cancer	3.63e-05	5.45e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PTGS2—head and neck cancer	3.15e-05	4.73e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PTEN—head and neck cancer	2.75e-05	4.12e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PIK3CA—head and neck cancer	1.94e-05	2.91e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—AKT1—head and neck cancer	1.58e-05	2.38e-05	CbGpPWpGaD
